ZA941958B - Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition - Google Patents

Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition

Info

Publication number
ZA941958B
ZA941958B ZA941958A ZA941958A ZA941958B ZA 941958 B ZA941958 B ZA 941958B ZA 941958 A ZA941958 A ZA 941958A ZA 941958 A ZA941958 A ZA 941958A ZA 941958 B ZA941958 B ZA 941958B
Authority
ZA
South Africa
Prior art keywords
protein
purification
pharmaceutical composition
reagent kit
steptococcus
Prior art date
Application number
ZA941958A
Other languages
English (en)
Inventor
Gunnar Lindahl
Margareth Stalhammar-Carlemalm
Lars Stenberg
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Publication of ZA941958B publication Critical patent/ZA941958B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA941958A 1993-03-19 1994-03-21 Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition ZA941958B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19

Publications (1)

Publication Number Publication Date
ZA941958B true ZA941958B (en) 1995-01-27

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941958A ZA941958B (en) 1993-03-19 1994-03-21 Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition

Country Status (18)

Country Link
US (1) US5869064A (hu)
EP (1) EP0656014B1 (hu)
JP (1) JP3976334B2 (hu)
KR (1) KR100331358B1 (hu)
CN (1) CN1046291C (hu)
AT (1) ATE240351T1 (hu)
CA (1) CA2158658A1 (hu)
DE (1) DE69432658T2 (hu)
DK (1) DK0656014T3 (hu)
ES (1) ES2194024T3 (hu)
HK (1) HK1008825A1 (hu)
HU (1) HU217582B (hu)
NZ (1) NZ263275A (hu)
PT (1) PT656014E (hu)
SG (1) SG47049A1 (hu)
SI (1) SI0656014T1 (hu)
WO (1) WO1994021685A1 (hu)
ZA (1) ZA941958B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
CN1268745C (zh) 1998-02-20 2006-08-09 生化制药有限公司 B组链球菌抗原
ES2281977T3 (es) * 1998-12-22 2007-10-01 Microscience Limited Proteinas de estreptococo del grupo b y su utilizacion.
HUP0201022A3 (en) * 1998-12-22 2004-07-28 Microscience Ltd Wokingham Outer surface proteins, their genes, and their use
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
ES2306528T3 (es) * 1998-12-23 2008-11-01 Id Biomedical Corporation Antigenos de streptococcus.
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
AU2002256921B2 (en) * 2001-05-31 2006-10-05 Fuso Pharmaceutical Industries Ltd. Improved method for detecting and identifying microorganism causative of infection
WO2002101037A1 (fr) * 2001-05-31 2002-12-19 Fuso Pharmaceutical Industries, Ltd. Procede d'evaluation de la fonction de phagocytose et utilisation associee
JP2005535287A (ja) * 2002-02-11 2005-11-24 アイディー バイオメディカル コーポレイション グループb連鎖球菌抗原
JP2008530021A (ja) * 2005-02-08 2008-08-07 アイディー バイオメディカル コーポレイション オブ ケベック シー.オー.ビー. アズ グラクソスミスクライン バイオロジカルズ ノース アメリカ 医薬組成物
US8313748B2 (en) 2007-04-16 2012-11-20 Minervax Aps Fusion protein vaccine
EP3365003A1 (en) 2015-10-21 2018-08-29 Minervax APS Immunogenic fusion protein
CA3004631A1 (en) 2015-12-30 2017-07-06 Minervax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
CA3066020A1 (en) 2017-06-16 2018-12-20 Glaxosmithkline Biologicals Sa Method of treatment
US20220387614A1 (en) 2019-11-22 2022-12-08 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp A vaccine made from polysaccharide and protein
JPH06506114A (ja) * 1991-03-29 1994-07-14 ファウルマン, エルビン 新規な遺伝子及びIgA結合蛋白質の製造方法

Also Published As

Publication number Publication date
HU217582B (hu) 2000-02-28
AU6389194A (en) 1994-10-11
SI0656014T1 (en) 2003-12-31
SG47049A1 (en) 1998-03-20
JPH09500092A (ja) 1997-01-07
WO1994021685A1 (en) 1994-09-29
HU9501993D0 (en) 1995-08-28
CN1119442A (zh) 1996-03-27
KR100331358B1 (ko) 2002-08-13
CN1046291C (zh) 1999-11-10
JP3976334B2 (ja) 2007-09-19
DE69432658D1 (de) 2003-06-18
DK0656014T3 (da) 2003-08-11
DE69432658T2 (de) 2004-04-08
NZ263275A (en) 1997-07-27
EP0656014B1 (en) 2003-05-14
US5869064A (en) 1999-02-09
ES2194024T3 (es) 2003-11-16
KR960701096A (ko) 1996-02-24
HK1008825A1 (en) 1999-05-21
AU681130B2 (en) 1997-08-21
PT656014E (pt) 2003-09-30
CA2158658A1 (en) 1994-09-29
ATE240351T1 (de) 2003-05-15
HUT72841A (en) 1996-05-28
EP0656014A1 (en) 1995-06-07

Similar Documents

Publication Publication Date Title
ZA941958B (en) Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition
DE262192T1 (de) Verfahren und mittel zur herstellung eines proteins mit dergleichen igg-spezifizitaet wie protein g.
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
ES8504460A1 (es) Procedimiento para producir la totalidad o parte de las subunidades a y b de la toxina del colera
AU1672388A (en) Expression of human proapolipoprotein a-i
AU1026692A (en) Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
ATE323721T1 (de) Cholin-bindendes protein, welches als gegen pneumokokken gerichtetes vakzin verwendet wird
NO20006191L (no) Vaksine
ZA859437B (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
GR3034766T3 (en) Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections.
EP0554389A4 (en) Molecular clones of hiv-1 and uses thereof
MX9606463A (es) Secuencias de nucleotido de las cepas pestivirus, polipeptidos codificados por estas secuencias y usos de los mismos para la diagnosis y prevencion de infecciones con pestivirus.
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
GB2324093A (en) Helicobacter pylori bacterioferritin
GB9409985D0 (en) Vaccine against mycobacterial infections
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
WO1998006841A3 (en) Two human nsp-like proteins
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
Schmidt et al. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
WO1997035982A3 (en) Monocyte chemotactic protein-5 materials and methods
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci